Ⅲ型前列腺炎综合治疗效果分析

A New Comprehensive Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndromes

目的探讨Ⅲ型前列腺炎综合治疗的作用及疗效。方法选择我院门诊就诊、病程3个月以上的Ⅲ型前列腺炎患者40例,口服复方玄驹胶囊,6周为1疗程,合并应用左氧氟沙星口服10 d,热水坐浴7～10 d,同时进行有规律的性生活。分别于治疗前及治疗结束后进行美国国立卫生研究院慢性前列腺炎症状指数(NIH-CPSI)评分,同时参考治疗后前列腺按摩液(EPS)常规检查结果作为疗效评价指标。结果 40例患者治愈5例(12.5%),显效10例(25.0%),有效18例(45.0%),无效7例(17.5%)。治疗结束后NIH-CPSI总分及症状评分分别为(15.7±8.2)和(10.4±5.6)分,较治疗前评分〔(27.2±6.1)分和(18.4±4.7)分〕明显降低,差异均有统计学意义(P<0.01)。治疗前前列腺液常规正常者8例(8/40),治疗后前列腺液常规正常者35例(35/40),差异有统计学意义(P<0.05)。本组无不良反应发生。结论Ⅲ型前列腺炎经综合治疗收到了良好效果,改善了临床症状。

Objective To explore the effect of a new comprehensive treatment of chronic prostatitis /chronic pelvic pain syndromes（CP/CPPS）.Methods A total of 40 CP/CPPS patients whose course was over 3 months were given oral Xuanju capsules,6 weeks as a course,combined with oral levofloxacin,10 d,and hot hip bath and regular sex life were suggested.U.S.National Institutes of Health Chronic Prostatitis Symptom Index（NIH-CPSI） scores were performed before or after treatment,taking posttreatment expressed prostatic secretions（EPS） routine test results as evaluation indexes for curative effect.Results Five patients were cured（12.5%）,10 had obvious effectiveness（25.0%）,18 had effectiveness（45.0%）,7 had no effectiveness（17.5%）.The total score of NIH-CPSI and symptom score were 15.7±8.2,10.4±5.6,respectively,after treatment,lower than before treatment（27.2±6.1,18.4±4.7,respectively）,the difference was significant（P0.01）.Eight patients had normal EPS routine test results（8/40） before treatment,but 35 patients did after treatment（35/40）,the difference was significant（P0.05）.There were no adverse reactions occurring.Conclusion The new comprehensive treatment,having good effect on CP/CPPS,can improve clinical symptoms.